凱龍高科(300912.SZ):公司碳化硅尚未對外銷售 對今年整體經營業績無重大影響
格隆匯6月8日丨凱龍高科(300912.SZ)公佈,公司就在微信公眾號發佈的報道進行更正及澄清説明:公司無法證明凱龍高科為國內首家能夠生產適用於道路國六後處理產品的重結晶碳化硅DPF企業,報道存在不嚴謹、不準確的情形。子公司重結晶碳化硅產品並未直接對外銷售,主要與母公司相關產品配套後對外出售,公司碳化硅尚未對外銷售,預計對2023年整體經營業績無重大影響。公司在公眾號文中提及的一季度商用車與非道路訂單暴升,存在不嚴謹情形。公司2023年1-2月實際訂單為2.49億元,同比下降7.03%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.